SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001178913-12-001000
Filing Date
2012-04-04
Accepted
2012-04-04 16:21:36
Documents
11
Period of Report
2012-02-29

Document Format Files

Seq Description Document Type Size
1 10-Q zk1211274.htm 10-Q 645926
2 EXHIBIT 31.1 exhibit_31-1.htm EX-31.1 14610
3 EXHIBIT 31.2 exhibit_31-2.htm EX-31.2 15470
4 EXHIBIT 32.1 exhibit_32-1.htm EX-32.1 7313
5 EXHIBIT 32.2 exhibit_32-2.htm EX-32.2 7113
  Complete submission text file 0001178913-12-001000.txt   2114359

Data Files

Seq Description Document Type Size
6 INSTANCE DOCUMENT ormp-20120229.xml EX-101.INS 175025
7 TAXONOMY EXTENSION SCHEMA ormp-20120229.xsd EX-101.SCH 16088
8 TAXONOMY EXTENSION CALCULATION LINKBASE ormp-20120229_cal.xml EX-101.CAL 38608
9 TAXONOMY EXTENSION LABEL LINKBASE ormp-20120229_lab.xml EX-101.LAB 242760
10 TAXONOMY EXTENSION PRESENTATION LINKBASE ormp-20120229_pre.xml EX-101.PRE 96525
11 TAXONOMY EXTENSION DEFINITION LINKBASE ormp-20120229_def.xml EX-101.DEF 20796
Mailing Address 2 ELZA STREET JERUSALEM L3 93706
Business Address 2 ELZA STREET JERUSALEM L3 93706 011 972-54-7909058
ORAMED PHARMACEUTICALS INC. (Filer) CIK: 0001176309 (see all company filings)

IRS No.: 980376008 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-Q | Act: 34 | File No.: 000-50298 | Film No.: 12742116
SIC: 2834 Pharmaceutical Preparations